# Novel Imaging Technique to Assess Gynecologic Cancer

> **NCT04893434** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 24 (actual)

## Conditions studied

- Gynecologic Cancer

## Interventions

- **DRUG:** Gadobutrol
- **DIAGNOSTIC_TEST:** MRI

## Key facts

- **NCT ID:** NCT04893434
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-13
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893434, "Novel Imaging Technique to Assess Gynecologic Cancer". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04893434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*